{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:21:55Z","timestamp":1790558515027,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Helicobacter pylori (H. pylori)<\/jats:italic>\n                      is a gram-negative bacterium infecting over 40% of the global population, with highest prevalence in low- and middle-income regions. Chronic infection leads to persistent gastritis and can result in peptic ulcer disease, dyspepsia and gastric adenocarcinoma. Despite its high pathogenic potential, population-based screening and eradication programmes remain limited, particularly in Europe.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This narrative review summarisescurrent evidence on the epidemiology, clinical burden and eradication strategies for\n                      <jats:italic>H. pylori<\/jats:italic>\n                      . A literature search of PubMed, Embase and the Cochrane Database was performed to identify recent publications relating to\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection, consequences and screening approaches.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>H. pylori<\/jats:italic>\n                      has been classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen and is the leading cause of infection-attributable cancer worldwide, accounting for approximately 850,000 gastric cancer cases annually. Robust evidence demonstrates that eradication of\n                      <jats:italic>H. pylori<\/jats:italic>\n                      reduces the risk of peptic ulcer recurrence, dyspepsia, and gastric cancer incidence, with recent meta-analyses reporting a pooled relative risk reduction of up to 44%. Population-based eradication initiatives, such as the Matsu Islands study, have shown dramatic declines in\n                      <jats:italic>H. pylori<\/jats:italic>\n                      prevalence, peptic ulceration, and gastric cancer incidence. Current international guidelines, including the Maastricht VI\/Florence and 2025 Taipei Global Consensus reports, now recommend universal eradication of confirmed infections and support population-level or family-based screening in high-risk regions. Ongoing European pilot studies, including the TOGAS initiative, aim to inform the implementation of gastric cancer screening programs. Concerns regarding antibiotic resistance remain, though recent evidence suggests that the risks are manageable with appropriate antibiotic stewardship.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Population-based\n                      <jats:italic>H. pylori<\/jats:italic>\n                      screen-and-treat strategies represent a cost-effective and evidence-based approach to preventing gastric cancer. Further large-scale European studies are warranted to guide optimal implementation, timing, and cost-effectiveness of such programs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgstr.2026.1740221","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:01:49Z","timestamp":1775019709000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The importance of Helicobacter pylori eradication: a narrative review"],"prefix":"10.3389","volume":"5","author":[{"given":"Orlaith","family":"Casey","sequence":"first","affiliation":[{"name":"Beacon Hospital Research Institute, Beacon Hospital","place":["Dublin, Ireland"]},{"name":"Department of Gastroenterology, Connolly Hospital, Blanchardstown","place":["Dublin, Ireland"]},{"name":"School of Postgraduate Studies, Royal College of Surgeons in Ireland","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dobric","sequence":"additional","affiliation":[{"name":"Beacon Hospital Research Institute, Beacon Hospital","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlaith","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Connolly Hospital, Blanchardstown","place":["Dublin, Ireland"]},{"name":"School of Postgraduate Studies, Royal College of Surgeons in Ireland","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm Antoine","family":"O\u2019Morain","sequence":"additional","affiliation":[{"name":"Beacon Hospital Research Institute, Beacon Hospital","place":["Dublin, Ireland"]},{"name":"School of Medicine, Trinity College Dublin","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","volume":"19","author":"Eusebi","year":"2014","journal-title":"Helicobacter"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13060541","article-title":"Current and future perspectives on the management of Helicobacter pylori: a narrative review","volume":"13","author":"Deane","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12945","article-title":"Transmission routes and patterns of helicobacter pylori","volume":"28","author":"Duan","year":"2023","journal-title":"Helicobacter"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9122502","article-title":"An overview of Helicobacter pylori survival tactics in the hostile human stomach environment","volume":"9","author":"Cheok","year":"2021","journal-title":"Microorganisms"},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.micres.2018.09.011","article-title":"Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases","volume":"218","author":"Karkhah","year":"2019","journal-title":"Microbiol Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"B9","first-page":"33","volume-title":"Population-based helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation","author":"Morgan","year":"2025"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12060969","article-title":"Helicobacter pylori infection: antibiotic resistance and solutions for effective management in Africa","volume":"12","author":"Setshedi","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00005","article-title":"Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression","volume":"9","author":"D\u00edaz","year":"2018","journal-title":"Front Microbiol"},{"key":"B12","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91545-5","article-title":"Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study","volume":"2","author":"Coghlan","year":"1987","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90929-4","article-title":"Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori","volume":"2","author":"Marshall","year":"1988","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N Engl J Med"},{"key":"B17","first-page":"1","article-title":". Schistosomes, liver flukes and Helicobacter pylori","volume":"61","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"153261","DOI":"10.1016\/j.tox.2022.153261","article-title":"Identification of substances with a carcinogenic potential in spray-formulated engine\/brake cleaners and lubricating products, available in the European Union (EU) - based on IARC and EU-harmonised classifications and QSAR predictions","volume":"477","author":"S\u00f8rli","year":"2022","journal-title":"Toxicology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm11164822","article-title":"Helicobacter pylori infection and chronic immune thrombocytopenia","volume":"11","author":"Takeuchi","year":"2022","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/gut.52.4.496","article-title":"Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia","volume":"52","author":"Annibale","year":"2003","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2004.02.008","article-title":"Helicobacter pylori impairs iron absorption in infected individuals","volume":"36","author":"Ciacci","year":"2004","journal-title":"Dig Liver Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70192-1","article-title":"Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults","volume":"115","author":"Milman","year":"1998","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins9040132","article-title":"Helicobacter pylori strains and gastric MALT lymphoma","volume":"9","author":"Floch","year":"2017","journal-title":"Toxins (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","article-title":"Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG)","volume":"9","author":"Malfertheiner","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection--the Maastricht 2\u20132000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection--the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"7","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-336027","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II","volume":"74","author":"Liou","year":"2025","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322200","article-title":"Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands","volume":"70","author":"Chiang","year":"2021","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02236-4","article-title":"Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group","volume":"355","author":"Moayyedi","year":"2000","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04610.x","article-title":"Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study","volume":"33","author":"Lane","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"B36","first-page":"53","volume-title":"Population-based helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation","author":"Moayyedi","year":"2025"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B38","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.12.033","article-title":"Eradication therapy to prevent gastric cancer in Helicobacterpylori-positive individuals: systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"169","author":"Ford","year":"2025","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/j.gastro.2025.01.239","article-title":"Risk of gastric adenocarcinoma after eradication of Helicobacter pylori","volume":"169","author":"Wiklund","year":"2025","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1177\/004947559202200302","article-title":"Letter from denis burkitt","volume":"22","author":"Burkitt","year":"1992","journal-title":"Trop Doct"},{"key":"B42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1053\/j.gastro.2024.11.001","article-title":"AGA clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the United States: expert review","volume":"168","author":"Shah","year":"2025","journal-title":"Gastroenterology"},{"key":"B43","volume-title":"Population-based helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation","author":"Tepe\u0161","year":"2025"},{"key":"B44","volume-title":"Population-based helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation","author":"Teng","year":"2025"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12186","article-title":"Trends in Helicobacter pylori infection among M\u0101ori, Pacific, and European birth cohorts in New Zealand","volume":"20","author":"McDonald","year":"2015","journal-title":"Helicobacter"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hel.12439","article-title":"Epidemiology of Helicobacter pylori infection in asymptomatic schoolchildren in Bhutan","volume":"22","author":"Wangda","year":"2017","journal-title":"Helicobacter"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.14887","article-title":"Screening for Helicobacter pylori to prevent gastric cancer: a pragmatic randomized clinical trial","volume":"332","author":"Lee","year":"2024","journal-title":"Jama"},{"key":"B48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.52787\/agl.v54i4.456","article-title":"Prevention of gastric cancer: Latin American context and experience","volume":"54","author":"Laudanno","year":"2024","journal-title":"Acta Gastroenerol Latinoam"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332705","article-title":"Where are we with gastric cancer screening in Europe in 2024","volume":"73","author":"Leja","year":"2024","journal-title":"Gut"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70118-6","article-title":"Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status","volume":"116","author":"Gillen","year":"1999","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1136\/bmj.38082.626725.EE","article-title":"Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project","volume":"328","author":"Harvey","year":"2004","journal-title":"Bmj"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12194","article-title":"Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis","volume":"27","author":"Nie","year":"2014","journal-title":"Dis Esophagus"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1953497","article-title":"Systematic review with meta-analysis: Association of Helicobacter pylori infection with esophageal cancer","volume":"2019","author":"Gao","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"B54","volume-title":"Population-based helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation","author":"Moayyedi","year":"2025"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: A systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00953-7","article-title":"The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis","volume":"23","author":"Ding","year":"2023","journal-title":"Clin Exp Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/antibiotics13111004","article-title":"In vitro susceptibility and synergistic effect of bismuth against Helicobacter pylori","volume":"13","author":"Woo","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2019.04.011","article-title":"Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics","volume":"157","author":"Fallone","year":"2019","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1592977","article-title":"The impact of Helicobacter pylori infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis","volume":"15","author":"Albush","year":"2025","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1740221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:01:53Z","timestamp":1775019713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1740221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":59,"alternative-id":["10.3389\/fgstr.2026.1740221"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2026.1740221","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1740221"}}